PURPOSE:Cisplatin resistance is still a serious problem in clinic. However, the underlying mechanism remains unclear. In this study investigated the drug resistance of cisplatin by the cisplatin resistance cell line HCT116R.
Introduction
Colon cancer is one of the most common malignant tumors in the world. At present, there are more than 1 million new cases of colon cancer each year, which seriously endangers human life and quality of life [1] .Most patients with metastatic colorectal cancer are still incurable. The positive response ratio of combined chemotherapy for colon cancer is only 20-47%, and most patients have recurrence [2] .Cisplatin is widely used to treat varieties of cancers [3] . However, the drug resistance frequently occurs after a period of administration with effective response, and its specific mechanism is still not very clear [4] .It has been shown that long non-coding RNA (lncRNA)interacts with chromatin regulatory proteins, RNA-binding proteins, and small RNAs to form a functional complex, regulating multiple important life processes [5] [6] [7] .To investigate the role of lncRNA MIR4435-2HG in cisplatin resistance, we disrupted the expression of MIR44535-2HG in cisplatin resistant cells HCT116R and these cells became sensitive to cisplatin. At the same time, Nrf2 and HO-1 mRNA level also decreased.
Materials and methods:
Cell culture and reagents.
The colon cancer cell line HCT-116 was purchased from the American Type Culture Collection (Manassas,VA, USA). This is the cisplatin-sensitive cell lineand the cisplatin-resistant HCT-116R cell line was established from the parental HCT-116 cells by selection against cisplatin in the laboratory. Both HCT-116 and HCT-116R cells were maintained as a monolayer inMcCoy's 5A medium (Gibco, Life Technologies, USA)supplemented with 10% fetal bovine serum, penicillin (100 U/ml),and streptomycin (100 μg/ml) in a humidified atmosphere of 5%CO2 at 37˚C.Scramble and MIR4435-2HG siRNA were purchased from Thermo Fisher(China) and siRNA transfections were performed with Lipofectamine 2000 (LifeTechnologies).
Cell proliferation assays.
Cell proliferation was assessed with the WST-8 assay using Cell Counting Kit-8 (CCK-8) (DojindoLaboratories, Kumamoto, Japan). HCT-116 cells (5×10 3 /well) were seeded in 96-well plates and incubated for 24h. Cells wereincubated with or without 25μM cisplatin for 24h in McCoy's 5A medium. Each treatment was carried out in triplicate. After incubation, 10 μl CCK-8 reagent was added to each well, and theplates were incubated at 37˚C in an atmosphere of 5% CO2 for 4h.The optical density was then measured with a microplate reader(Multiskan JX; MTX Lab Systems, Vienna, VA, USA) at awavelength of 450 nm.
Total RNA Isolation and Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR).
Total RNA was isolated from treated cells usingthe TrizolReagent (Invitrogen, Carlsbad, CA),according to the manufacturer's instruction. RNAconcentration and quality were determined by aspectrophotometer (Beckman, Brea, CA) and gelelectrophoresis, respectively. First-strand cDNA wassynthesized using the M-MLV Reverse Transcriptasekit (Invitrogen, Carlsbad, CA) in a total volume of20 mL.qRT-PCR analysis for gene expressionwas performed in triplicate using the SYBR GreenThe primer sequences used were MIR4435-2HGforward:
5′-CAAGTCTCACACATCCGGGC-3;Nrf2Forward:
5′-TACTCCCAGGTTGCCCACA-3′, Nrf2Reverse:
5′-CATCTACAAACGGGAATGTCTGC-3′;HO-1Forward:
5′-CACGCATATACCCGCTACCT-3′, HO-1Reverse:
5′-AAGGCGGTCTTAGCCTCTTC-3′; GAPDHForward:
5′-TATGATGATATCAAGAGGGTAGT-3′, GAPDHReverse:
5′-TGTATCCAAACTCATTGTCATAC-3′.
Caspase-3 activity assay. Cells were seeded into the 96 well plate at the density of 5000 and allowed to grow for 24 h. Then the siRNAs targeting to MIR4435-2HGwere transfected byLipofectamine RNAiMAX (ThermoFisher, China) according to the instruction manual.Cells were collected after 24 h and the caspase activity was determined using the Caspase-3 Assay Kit (Colorimetric) (Abcam ab39401, Cambridge, UK).
Statistical analysis.
Data are expressed as the mean±standard errorof the mean. Statistical analyses were performed using Prism Graphpad 6.0 (GraphPad Software, San Diego, CA, USA). Statistical significance was determined at p<0.05.
Results.
The MIR4435 level is higher in HCT-116 cell line resistant to Cisplatin.
First, we induced the drug resistance of HCT116 to Cisplatin by adding 25μm
Cisplatin to HCT116 for 3 months, and we named it HCT-116R.The HCT-116R could proliferate with the presence of 25μm Cisplatin, while most HCT116 cells progressively die (Figure1A) .We detected the response to cisplatin. Then RNA-Seq was used to analyze the changing cellular transcriptome of HCT116 and HCT116R.
We found that the lncRNA MIR4435-2HG level dramatically increased about ten times and the result was verified with real-time PCR (Figure1B).
Knockdown of MIR4435-2HG increased the sensitivity of HCT-116R to Cisplatin.
To investigate the relationship of lncRNA MIR4435-2HG and cisplatin resistance, Nuclear factor erythroid 2-related factor 2 (Nrf2) is a keytranscription factor that regulates antioxidant anddetoxification enzymes and Heme oxygenase-1 (HO-1) is a
Nrf2-regulated gene that plays a critical role in the prevention of inflammation.
Transfection of MIR4435-2HG siRNA downregulated the mRNA levels of Nrf2 and HO1 significantly after the 25μM cisplatin treatment (Figure3), and this phenomenon indicated the role of MIR4435-2HG is involved the oxidative stress.
Discussion
Cisplatin is thought to formulate the covalent adducts with some bases in the DNA, then could cure many testicular and some ovarian carcinomas [8, 9] .
However,the efficiency of cisplatin is low in colorectal cancer(CRC), with fewer than 20% clinical responses whenused alone or in combination with other anti-cancer drugs [10] . Last few years, several studies suggested that some lncRNA contributed the cisplatin resistance via various different mechanism [11] .
LncRNA MIR4435-2HG has been reported to related with the hepatocellular carcinoma [12] and lung cancer [13] . Nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor, responses for the oxidative stresses and plays a key role in redox homeostasis [15] . Heme oxygenase (HO), acting as downstream of Nrf2 [16] , is an enzyme that catalyzes the degradation of heme [17, 18] . These two components usually increased in different types of tumors and correlate with tumor progression, aggressiveness, resistance to therapy, and poor prognosis [19] . In our system, the knockdown of MIR4435-2HG decreased the NRF2 and HO-1 mRNA level significantly.
Conclusions and Perspectives
This report we observed that lncRNA MIR4435-2HG as a main factor could drive the cisplatin resistance of HCT116.Moreover, lncRNA MIR4435-2HG might participate in the development of cisplatin resistance through the Nrf2/HO-1 pathway.The current study unveiled the roles of lncRNA MIR4435-2HG in colorectal cancer cisplatin resistance and provided the underlying mechanism of cisplatin resistance .
Based on the mechanisms underlying cisplatin resistance, the following strategies have been proposed to overcome the resistance in colorectal cancer in the future: 1) develop new platinum drugs;2) improve cisplatin delivery to tumor; 3) specifically target cisplatin resistance mechanisms; and 4) combine cisplatin with other drugs.Understanding the molecular mechanisms underlying cisplatin resistance may be helpful to identify patients with better treatment, and thus oncologists may be able to provide an effective therapy for those patients.
